The SLIMMER Phase 3 trial positioned ecnoglutide as a competitive GLP-1 agonist, with 15.4% weight loss at 48 weeks that approaches semaglutide's established efficacy, though the comparison is limited by differences in trial populations and duration
In clinical trials, the mean maximum systolic blood pressure increase was approximately 6 mmHg , typically occurring 12 hours post-injection and resolving within 12 hours
Garshick said some users have reported not seeing any effects with taking melanotan II, which might prompt them to increase their dose
and (3) improved e-commerce access to niche nutricosmetic categories previously limited to dermatology clinics or specialty retailers
Freezing compounded tirzepatide can permanently damage the peptide structure, destroying its therapeutic activity and potentially creating safety concerns
In 2026, Boehringer Ingelheim says it believes opportunities will outweigh risks